The city of Orlando, Florida, currently has 15 active clinical trials seeking participants for Alzheimer's Disease research studies.
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
Recruiting
The primary purpose of this study is to identify participants with or without symptoms of Alzheimer's Disease (AD) that are at high risk for brain amyloid pathology using blood-based biomarkers.
Gender:
All
Ages:
Between 50 years and 80 years
Trial Updated:
11/21/2023
Locations: Eisai Site #2, Orlando, Florida
Conditions: Alzheimer's Disease
Long-Term Follow-up of Gene Therapy for APOE4 Homozygote Alzheimer's Disease
Recruiting
The primary purpose of this long-term follow-up study is to assess the long-term safety profile of APOE4 homozygote participants who were administered gene therapy (LX1001) for the treatment of Alzheimer's disease in Study LX100101. A secondary objective is to assess the biomarker as shown by the conversion of CSF APOE isoforms from APOE4 to APOE2-APOE4. Additional secondary outcomes include amyloid PET scan, CSF markers (including Aβ42, Aβ42/Aβ40 ratio T--tau, and P-tau), and quantitative MRI (... Read More
Gender:
All
Ages:
50 years and above
Trial Updated:
11/13/2023
Locations: PPD- Orlando Research Unit, Orlando, Florida
Conditions: Alzheimer Disease
Davos Alzheimer's Collaborative Study: Sequential Administration of Digital Testing To Screen For Cognitive Impairment Followed By Blood Based Biomarkers To Assist With Timely Detection And Accurate Diagnosis Of Alzheimer's Disease
Recruiting
The purpose of this study is to investigate how we can detect Alzheimer's disease early by using an online memory test and a simple blood test. These new methods for early diagnosis could allow people to begin treatment sooner, with the potential to improve the lives of millions of people.
Gender:
All
Ages:
65 years and above
Trial Updated:
04/03/2023
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Alzheimer Disease